View Older Stories View More Recent Stories
-
Orchid Island Capital Announces May 2026 Monthly Dividend and April 30, 2026 RMBS Portfolio Characteristics
-
Nexxen (NEXN) PT Raised to $11 at RBC Capital
-
Sarepta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
-
Form 13F-NT RBC Capital Markets, For: Mar 31
-
RBC Capital on NVIDIA (NVDA): 'Demand not an issue; Supply tightness manageable'
-
Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference
-
aTyr Pharma to Participate in Upcoming Investor Conferences
-
Makary exit may temporarily lift biotech sentiment but FDA leadership vacuum looms
-
Compass Pathways (CMPS) PT Raised to $22 at RBC Capital
-
ARAMARK Holdings (ARMK) PT Raised to $55 at RBC Capital
-
Community Health Systems to Participate in 2026 RBC Capital Markets Global Healthcare Conference
-
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Participate in Two May Investor Conferences
-
Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference
-
'Sunoco (SUN) Well Positioned to Exceed 2026 Guidance'; PT Raised to $78 at RBC Capital
-
'Ralliant Corp. (RAL) Rebounds with Solid 1Q26 Beat & Raise'; PT Raised at RBC Capital
-
Amentum Holdings Inc. (AMTM) PT Lowered to $28 at RBC Capital
-
Legend Biotech Corp. (LEGN) PT Raised to $64; RBC Capital: 'We see opportunity for share appreciation'
-
AECOM Technology (ACM) PT Lowered to $111 at RBC Capital
-
RBC Capital Reiterates PACS Group (PACS) as Top Pick
-
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
-
Valitor to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
-
Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences
-
Dyne Therapeutics to Participate in Upcoming Investor Conferences
-
Pyxis Oncology to Participate in Upcoming Investor Conferences
-
Dyne Therapeutics to Participate in Upcoming Investor Conferences
-
Trican Well Service (TCW:CN) (TOLWF) PT Raised to Cdn$8.50 at RBC Capital
-
Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference
-
Beam Therapeutics to Present at 2026 RBC Capital Markets Global Healthcare Conference
-
Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference
-
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Quintiles (Q) PT Raised to $200 at RBC Capital
-
RBC Capital Upgrades Mosaic (MOS) to Outperform
-
Fluence prices secondary offering at $21 per share
-
Fluence Announces Pricing of Secondary Offering of Class A Common Stock by Existing Controlling Stockholders
-
AEP prices stock offering at $127 per share
-
AEP ANNOUNCES PRICING OF COMMON STOCK OFFERING WITH A FORWARD COMPONENT
-
Fervo Energy raises $1.89 billion in US IPO
-
Fervo Energy prices upsized IPO at $27 per share
-
Fervo Energy Announces Pricing of its Upsized Initial Public Offering
-
Farmer Mac Prices $100 Million of Series I Preferred Stock
-
Tonix Pharmaceuticals to Participate in Two Investor Conferences in May
-
DiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
-
Contineum Therapeutics to Present at the 2026 RBC Capital Markets Global Healthcare Conference
-
Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update
-
Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference
-
Cytokinetics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
-
Targa Resources (TRGP) PT Raised to $281 at RBC Capital Amid Macro Tailwinds
-
Applied Materials (AMAT) PT Raised to $500 at RBC Capital On DRAM Strength
-
RBC Capital on Plug Power (PLUG): 'Good Start'
-
RBC Capital on Perspective Therapeutics (CATX): 'We see significant upside potential for investors with patience'

